Todd Verdoorn
Biochemistry
Dia Medica
Canada
Biography
Dr. Verdoorn has more than 26 years of experience working with both public and private pharmaceutical and biotechnology companies to develop new treatments for neurological diseases, including five years working with Bristol-Myers Squibb's stroke group and as the former Chief Scientific Officer for several private life sciences companies. Dr. Verdoorn earned his PhD in Neurobiology from the University of North Carolina, conducting his post-doctoral research at the Max Planck Institute with Nobel Laureate Dr. Bert Sakmann, served as Associate Professor of Pharmacology at Vanderbilt University School of Medicine and is the author of numerous publications and patents. Dr. Verdoorn was formerly Vice President of Neuroscience with DiaMedica.
Research Interest
Biochemistry
